| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? (US) |
| Identifiers | |
| CAS number | 9039-61-6 |
| ATC code | B02BX03 |
| Chemical data | |
| Formula | ? |
| |
|
Batroxobin is a serine protease[2] derived from the venom of Bothrops atrox. Its molecular weight is approximately 43,000 g/mol−1.
This thrombin-like proteolytic enzyme splits the 16 Arg-17 Gly bond in the A(alpha)-chain of fibrinogen, releasing fibrinopeptide A and leading to the clot formation through aggregation of formed of fibrin I monomer or Des-AA-monomer.[3]. In contrast to other anti-coagulants, it does not affect the functions of platelets. Hence, Batroxobin is used to determine fibrinogen in plasma, to measure a 'batroxobin clotting time' as a heparin-insensitive parallel to the thrombin time, to investigate dysfibrinogenemia, and to test the contractile system of platelets[4]
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||
| This hydrolase article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)